SEC Form 4 · accession 0001225208-18-005114
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sally Susman
Officer — Executive Vice President
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | M | 110,132 | $27.37 | A | 245,362 | D | |
| Common StockF2 | Feb 28, 2018 | F | 23,035 | $36.31 | D | 222,327 | D | |
| Common StockF3,F4 | Feb 28, 2018 | F | 66,850 | $35.70 | D | 155,477 | D | |
| Common Stock | holding | — | — | — | 646 | I | By Rule 16b-3 Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $27.37 | Feb 28, 2018 | M | 110,132 | D | Feb 28, 2018 | Feb 28, 2018 | Common Stock | 110,132 | 0 | D |
Explanation of responses
- F1The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- F2The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
- F3The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- F4Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.